Immunome Inc. Quarterly Return On Assets in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Immunome Inc. quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q3 2024.
  • Immunome Inc. Return On Assets for the quarter ending September 30, 2024 was -120 %, a 181% decline year-over-year.
  • Immunome Inc. annual Return On Assets for 2023 was -129 %, a 23.5% decline from 2022.
  • Immunome Inc. annual Return On Assets for 2022 was -104 %, a 140% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -120 -77.1 -181% Jul 1, 2024 Sep 30, 2024
Q2 2024 -122 -49.9 -68.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -154 -70.7 -84.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -129 -24.6 -23.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -42.5 +41.9 +49.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -72.6 -2.78 -3.98% Apr 1, 2023 Jun 30, 2023
Q1 2023 -83.3 -27.4 -49% Jan 1, 2023 Mar 31, 2023
Q4 2022 -104 -60.9 -140% Oct 1, 2022 Dec 31, 2022
Q3 2022 -84.4 -45.2 -115% Jul 1, 2022 Sep 30, 2022
Q2 2022 -69.8 -16.9 -31.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -55.9 Jan 1, 2022 Mar 31, 2022
Q4 2021 -43.5 Oct 1, 2021 Dec 31, 2021
Q3 2021 -39.2 Jul 1, 2021 Sep 30, 2021
Q2 2021 -52.9 Apr 1, 2021 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.